News Headlines

Display #
Title
Brain tissue from a petri dish
Tech Giant Apple Hires Secret Team of Biomedical Engineers for Treating Diabetes
Icon Bioscience Submits NDA for Dexycu, a Potential Transformational Drug Therapy for Treating Inflammation Associated with Cataract Surgery
University of California files CRISPR patents appeal
NextGen Healthcare Announces Agreement to Acquire Entrada Inc.
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds
U.S. FDA raises concerns over Teva’s plant in China
Bristol-Myers licenses two drugs to Biogen, Roche
FDA warns Abbott Labs over heart devices
UK cost agency turns down Bristol drug
Health risk assessments shed light on early predictors of depression
The accidental discovery of LSD
FDA Picks Emulate for Organ Chip Technology
Austrian biotech Themis launches Zika vaccine clinical trial
SEC Cracks Down on “Fake Biotech News”
The Human Vaccines Project, Vanderbilt And Illumina Join Forces To Decode The Human Immunome
India’s Strand Life Sciences launches blood test to detect cancer
U.S. guidelines relax opposition to prostate cancer screening
PatientsLikeMe and Shire Pharmaceuticals collaborate to study rare genetic diseases
Lots of sleep tied to worse breast cancer survival odds
Roche’s Alecensa notches trial win against Pfizer’s Xalkori
Phase III study shows Roche's Alecensa was superior to crizotinib in a specific type of lung cancer
Dalian Wanda to invest $10 billion in China healthcare hub
The first live-attenuated vaccine candidate completely protects against Zika infection
Stada Accepts $5.6 Billion Takeover Offer
Three Drug Giants That Boasts the Best Pipelines
OncoMed sinks as cancer drug fails
Pancreatic Cancer Pathway Identified; Discovery May Broach New Era of Effective Immunotherapies for the Deadliest Major Cancer
Medtronic recalls devices used to manage fluid build-up in the brain
Four-Person Biotech Pens R&D Deal Worth $1 Billion With Drug Giant Novartis